<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Tanycytes in Energy Balance and Neurodegeneration</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Tanycytes in Energy Balance and Neurodegeneration</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Tanycytes in Energy Balance and Neurodegeneration</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>Tanycytes in Energy Balance and Neurodegeneration</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>
Tanycytes represent a specialized population of radial glial-like ependymal cells that line the floor and walls of the third ventricle in the [hypothalamus](/brain-regions/hypothalamus). First characterized in the 1960s, these elongated cells possess a unique morphology with a cell body adjacent to the ventricular surface and a long basal process extending toward the hypothalamic parenchyma. Tanycytes serve as critical interface cells between the brain and peripheral circulation, functioning as neural stem cells, metabolic sensors, and gatekeepers of the median eminence barrier. [@lee2023] Their strategic position within the hypothalamic region, which governs fundamental homeostatic functions, positions tanycytes as key players in the intersection between metabolic dysfunction and neurodegenerative disease processes.
The study of tanycytes has undergone a renaissance in recent years, with emerging evidence demonstrating their essential roles in energy homeostasis, adult neurogenesis, and neuroimmune regulation. These discoveries have profound implications for understanding the pathophysiology of [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and related neurodegenerative disorders, which frequently present with accompanying metabolic disturbances. [@prevot2024] The bidirectional relationship between tanycyte dysfunction and neurodegeneration represents an exciting frontier in neuroscience research, offering potential therapeutic targets for diseases characterized by both cognitive decline and metabolic impairment.
Tanycytes are classically divided into two major subtypes based on their anatomical location and functional properties. Alpha tanycytes reside primarily in the median eminence and organum vasculosum of the lamina terminalis, where they surround the portal capillaries and function as specialized glial cells that regulate neuroendocrine communication. These cells extend thick, elongated processes that ensheath portal vessels and neurons of the arcuate nucleus, creating a structural barrier that controls the passage of molecules between the brain and pituitary circulation. Alpha tanycytes demonstrate limited neurogenic capacity but play essential roles in metabolic sensing and endocrine regulation. [@goodyear2022]
Beta tanycytes, in contrast, line the walls of the third ventricle and retain more robust neural stem cell properties. These cells can give rise to new neurons in the adult hypothalamus, particularly in response to metabolic challenges or environmental enrichment. Beta tanycytes maintain direct access to the cerebrospinal fluid and coordinate information flow between the ventricular system and hypothalamic neural circuits. The distinction between alpha and beta tanycytes, while anatomically useful, represents a spectrum of phenotypic variation rather than rigid categorization, as hybrid populations displaying mixed characteristics have been identified. [@bolb2022]
The median eminence represents a specialized circumventricular organ lacking a complete blood-brain barrier, permitting direct communication between hypothalamic neurons and peripheral circulation. Tanycytes constitute the primary cellular component of this barrier, regulating the movement of hormones, nutrients, and signaling molecules between the brain and blood. The tanycytic barrier functions through tight junction complexes between adjacent cells, selective transporter expression, and active endocytic mechanisms that control molecular passage. This barrier function becomes particularly relevant in neurodegenerative diseases, where dysregulation of peripheral-central signaling contributes to disease progression. [@kaur2022]
Tanycytes function as central metabolic sensors, detecting fluctuations in circulating glucose, lipids, and hormones to coordinate hypothalamic regulatory mechanisms. These cells express glucose transporters, including GLUT1 and GLUT2, enabling them to sense blood glucose levels and translate this information into neural signals that regulate feeding behavior, energy expenditure, and glucose homeostasis. Tanycytes respond to changes in ambient glucose concentration by modulating their electrophysiological properties and releasing signaling molecules that influence adjacent neurons in the arcuate nucleus. This glucose sensing capacity positions tanycytes as critical integrators of metabolic state and neural circuit activity. [@robins2023]
Beyond glucose, tanycytes detect circulating lipids and respond to changes in fatty acid composition through activation of peroxisome proliferator-activated receptors (PPARs) and other lipid-sensitive transcription factors. High-fat diet consumption induces structural and functional alterations in tanycytes, including barrier disruption, inflammatory activation, and impaired neurogenic capacity. These diet-induced changes may contribute to the established link between obesity and increased neurodegenerative disease risk, as tanycyte dysfunction could propagate metabolic dysfunction throughout the brain. [@du2020]
Tanycytes express receptors for multiple metabolic hormones, including leptin, ghrelin, insulin, and thyroid hormone, enabling them to respond to systemic hormonal cues and modulate hypothalamic function accordingly. Leptin signaling in tanycytes regulates food intake and energy expenditure through effects on arcuate nucleus neurons expressing neuropeptide Y (NPY) and proopiomelanocortin (POMC). The importance of tanycytes in leptin signaling is highlighted by studies demonstrating that selective deletion of leptin receptors from tanycytes produces metabolic dysregulation comparable to global leptin receptor deficiency. [@schmidt2020]
Ghrelin, the orexigenic hormone secreted by the stomach, also acts on tanycytes to stimulate food intake and growth hormone release. Tanycytes respond to ghrelin by releasing factors that stimulate NPY/AgRP neurons and inhibit POMC neurons, promoting feeding behavior. This hormonal integration capacity makes tanycytes essential nodes in the neural circuits governing energy balance, and their dysfunction may contribute to the metabolic disturbances observed in neurodegenerative disease patients.
[Alzheimer's disease](/diseases/alzheimers-disease) and metabolic disorders share bidirectional relationships, with each condition increasing risk for the other. Type 2 diabetes mellitus approximately doubles the risk of developing AD, while patients with AD frequently exhibit hypothalamic dysfunction, energy imbalance, and altered hormone levels. Tanycytes provide a mechanistic link between these conditions, as their metabolic sensing functions become impaired in the context of systemic metabolic dysfunction. [@zhang2021] Tanycyte dysfunction may contribute to AD pathogenesis through several interconnected mechanisms.
Elevated peripheral inflammation associated with metabolic syndrome accesses the brain through the median eminence, where compromised tanycyte barrier function permits inflammatory mediator passage to hypothalamic neurons. This inflammatory activation triggers neuroinflammation in hypothalamic regions, which spreads to limbic structures including the [hippocampus](/brain-regions/hippocampus) and entorhinal cortex—areas critical for memory function. The tanycyte-mediated inflammatory gateway thus represents a potential pathway through which peripheral metabolic dysfunction contributes to central neurodegeneration. [@yang2019]
Tanycytes may interact directly with [amyloid-beta](/proteins/amyloid-beta) (Aβ) and [tau](/proteins/tau) pathology, the cardinal protein aggregates in AD. Aβ accumulation in the hypothalamus has been documented in AD patients and animal models, with particular vulnerability of tanycytic populations. Aβ exposure disrupts tanycyte barrier function, reduces neurogenic capacity, and induces inflammatory activation. Conversely, tanycyte dysfunction may accelerate Aβ accumulation by impairing clearance pathways and promoting neuroinflammation that drives amyloid production. This bidirectional relationship creates a vicious cycle that accelerates disease progression. [@hernandez2022]
Tau pathology also affects tanycytes in AD, with phosphorylated tau accumulating within these cells in response to neuronal degeneration and inflammatory signals. Tau pathology in tanycytes may impair their metabolic sensing and neurogenic functions, further disrupting hypothalamic homeostasis. The presence of tau in tanycytes represents an early pathological change that could serve as a biomarker for preclinical AD, although this remains an active area of investigation.
[Parkinson's disease](/diseases/parkinsons-disease) patients frequently exhibit metabolic disturbances, including weight loss, dysregulated glucose metabolism, and altered hormone levels. Type 2 diabetes increases PD risk by approximately 40%, and metabolic dysfunction correlates with faster disease progression and more severe motor symptoms. Tanycytes may contribute to these metabolic aspects of PD through their roles in energy homeostasis and neuroendocrine regulation. The hypothalamic dysfunction observed in PD, including sleep disturbances, autonomic dysfunction, and metabolic changes, may reflect underlying tanycyte pathology. [@muller2021]
The hallmark protein aggregation in PD, [alpha-synuclein](/proteins/alpha-synuclein), may directly affect tanycyte function. Alpha-synuclein accumulation has been documented in the hypothalamus of PD patients, with particular involvement of tanycytic populations. This pathological accumulation disrupts normal cellular functions, including protein homeostasis, mitochondrial function, and inflammatory regulation. Tanycyte dysfunction could therefore contribute to the hypothalamic dysfunction that characterizes PD and may influence non-motor symptoms including sleep disruption, appetite dysregulation, and autonomic impairment.
Tanycytes function as gatekeepers controlling the passage of inflammatory molecules from peripheral circulation into the brain parenchyma. Under normal conditions, the tanycytic barrier restricts immune cell and cytokine entry, protecting the hypothalamic region from peripheral inflammatory challenges. However, this barrier becomes compromised in neurodegenerative diseases, permitting excessive inflammatory signaling that activates hypothalamic microglia and propagates [neuroinflammation](/mechanisms/neuroinflammation) throughout the brain. [@kaur2022]
The median eminence represents a particularly vulnerable entry point for peripheral inflammatory signals due to its incomplete blood-brain barrier. Compromised tanycyte barrier function permits pro-inflammatory cytokines including interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) to access hypothalamic neurons, triggering inflammatory activation that disrupts neural circuit function. This inflammatory gateway mechanism may explain the association between peripheral inflammatory conditions and neurodegenerative disease risk. [@klingp2021]
The central role of tanycytes in neuroimmune regulation suggests several therapeutic approaches for neurodegenerative diseases. Enhancing tanycyte barrier function through pharmacological intervention could reduce peripheral-central inflammatory signaling and slow disease progression. Targeting tanycyte-specific inflammatory pathways, including cytokine receptors and intracellular signaling cascades, offers the potential for targeted anti-inflammatory therapy without systemic immunosuppression. Additionally, promoting tanycyte-mediated neurogenesis could help replace lost neurons and restore hypothalamic function in neurodegenerative conditions. [@fernandez2023]
The recognition that tanycytes function as neural stem cells in the adult hypothalamus represents a significant advance in understanding brain plasticity. Under appropriate conditions, tanycytes can generate new neurons that integrate into hypothalamic neural circuits, potentially contributing to metabolic regulation and homeostasis. This neurogenic capacity declines with age, paralleling the age-related increase in neurodegenerative disease risk. Enhancing tanycyte neurogenesis represents a potential therapeutic strategy for restoring hypothalamic function in aging and disease. [@bolb2022]
Aging produces multiple changes in tanycyte function, including reduced metabolic sensing capacity, diminished barrier integrity, and impaired neurogenesis. These age-related changes may contribute to the increased prevalence of neurodegenerative diseases in elderly populations by creating a hypothalamic environment permissive to pathological protein aggregation and neuroinflammation. Understanding the mechanisms underlying tanycyte aging could identify therapeutic targets for promoting healthy brain aging and preventing neurodegeneration.
Tanycytes occupy a unique position at the interface between brain and body, serving as metabolic sensors, neural stem cells, and gatekeepers of hypothalamic homeostasis. Their dysfunction contributes to the metabolic disturbances that accompany [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related neurodegenerative conditions, while also promoting neuroinflammation that accelerates disease progression. The emerging understanding of tanycyte biology offers promising therapeutic opportunities for addressing the metabolic and inflammatory components of neurodegenerative disease, potentially complementing approaches targeting classical pathological proteins. Future research examining tanycyte function in human neurodegenerative disease and developing tanycyte-targeted therapies represents a critical frontier in the field.